A C.D.C. panel will meet today on the Johnson & Johnson vaccine pause.

The U.S. government is likely to end the pause if the panel says the vaccine’s benefits outweigh the potential risk.

from NYT > Health https://ift.tt/3gxv4WJ
via health&fitness